Federated Hermes’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-38,314
Closed -$3.02M – 2124
2024
Q3
$3.02M Hold
38,314
– – 0.01% 841
2024
Q2
$2.76M Sell
38,314
-850
-2% -$50.9K 0.01% 849
2024
Q1
$3.85M Sell
39,164
-917
-2% -$80.7K 0.01% 783
2023
Q4
$2.93M Sell
40,081
-9,853
-20% -$582K 0.01% 850
2023
Q3
$3.33M Buy
49,934
+38,218
+326% +$3.52M 0.01% 796
2023
Q2
$1.12M Sell
11,716
-39
-0.3% -$3.89K ﹤0.01% 1109
2023
Q1
$1.18M Buy
11,755
+2,984
+34% +$457K ﹤0.01% 1119
2022
Q4
$1.52M Sell
8,771
-18,708
-68% -$12.3M ﹤0.01% 1001
2022
Q3
$26.3M Sell
27,479
-16,602
-38% -$16.5M 0.08% 315
2022
Q2
$29.5M Hold
44,081
– – 0.08% 299
2022
Q1
$30.6M Buy
44,081
+7,053
+19% +$5.44M 0.07% 342
2021
Q4
$33.5M Hold
37,028
– – 0.06% 357
2021
Q3
$37.2M Hold
37,028
– – 0.07% 341
2021
Q2
$24.1M Sell
37,028
-6,250
-14% -$4.34M 0.04% 439
2021
Q1
$32M Sell
43,278
-28
-0.1% -$22.6K 0.06% 378
2020
Q4
$33.5M Buy
43,306
+18,068
+72% +$14.2M 0.07% 334
2020
Q3
$25.1M Buy
25,238
+1,556
+7% +$1.65M 0.06% 367
2020
Q2
$24.6M Buy
23,682
+4,717
+25% +$4.75M 0.06% 350
2020
Q1
$15.4M Buy
18,965
+4,562
+32% +$4.77M 0.05% 390
2019
Q4
$18M Buy
14,403
+2,760
+24% +$4.45M 0.04% 438
2019
Q3
$15.6M Hold
11,643
– – 0.04% 428
2019
Q2
$20.7M Buy
11,643
+2,418
+26% +$3.7M 0.05% 343
2019
Q1
$16M Buy
+9,225
New +$15.4M 0.04% 405

Other funds holding GOSS

Federated Hermes's GOSS Position: Q4 2024 in Review

Federated Hermes sold out of Gossamer Bio (GOSS) in Q4 2024, closing a stake of 38,314 shares — an estimated $3.02M sold.

Federated Hermes first reported a position in GOSS in Q1 2019 and held it in 23 quarters. The position peaked at $37.2M in Q3 2021. 102 funds tracked by Wall St. Rank hold GOSS as of Q4 2024.

  • Federated Hermes reported no remaining Gossamer Bio position as of Q4 2024 after selling out during the quarter.
  • Federated Hermes sold 38,314 Gossamer Bio shares in Q4 2024, an estimated $3.02M.
  • Federated Hermes first reported a position in Gossamer Bio in Q1 2019 and held it in 23 quarters.
  • Federated Hermes's Gossamer Bio position peaked at $37.2M in Q3 2021.
  • 102 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2024.

Based on Federated Hermes's 13F filing for Q4 2024, filed 13 Feb 2025.